435
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Electroconvulsive therapy for super refractory status epilepticus in pregnancy: case report and review of literature

, ORCID Icon, , &
Pages 1109-1119 | Received 03 May 2021, Accepted 25 Feb 2022, Published online: 14 Mar 2022

References

  • Brophy GM, Neurocritical Care Society Status Epilepticus Guideline Writing Committee, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23.
  • Dham BS, Hunter K, Rincon F. The epidemiology of status Epilepticus in the United States. Neurocrit Care. 2014;20(3):476–83.
  • Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134(Pt 10):2802–2818.
  • Rossetti AO. Treatment options in the management of status epilepticus. Curr Treat Opt Neurol. 2010;12(2):100–112.
  • Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011;10(10):922–930.
  • Bodenant M, Moreau C, Sejourne C, … SA-R, 2008. undefined. Interest of the ketogenic diet in a refractory status epilepticus in adults. [cited 2021 Nov 19]. Available at europepmc.org. https://europepmc.org/article/med/18358881.
  • Cervenka MC, Hartman AL, Venkatesan A, et al. The ketogenic diet for medically and surgically refractory status epilepticus in the neurocritical care unit. Neurocrit Care. 2011;15(3):519–524.
  • Corry JJ, Dhar R, Murphy T, et al. Hypothermia for refractory status epilepticus. Neurocrit Care. 2008;9(2):189–197.
  • Seshadri M, Nadeem Z M-K. Response predictors in ECT: a discussion about seizure threshold. BJMP. 2011;4(2):a424.
  • Ward HB, Fromson JA, Cooper JJ, et al. Recommendations for the use of ECT in pregnancy: Literature review and proposed clinical protocol. Arch Womens Ment Health. 2018;21(6):715–722.
  • Gjerde IO, Strandjord RE, Ulstein M. The course of epilepsy during pregnancy: a study of 78 cases. Acta Neurol Scand. 1988;78(3):198–205.
  • Bardy AH. Incidence of seizures during pregnancy, labor and puerperium in epileptic women: a prospective study. Acta Neurol Scand. 1987;75(5):356–360.
  • Tomson T, Lindbom U, Ekqvist B, et al. Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin. Epilepsia. 1994;35(1):122–130.
  • Battino D, EURAP Study Group, Tomson T, Bonizzoni E, et al. Seizure control and treatment changes in pregnancy: Observations from the EURAP epilepsy pregnancy registry. Epilepsia. 2013;54(9):1621–1627.
  • Kusznir Vitturi B, Barreto Cabral F, Mella Cukiert C. Outcomes of pregnant women with refractory epilepsy. Seizure. 2019;69:251–257.
  • Harden CL, American Epilepsy Society, Hopp J, Ting TY, et al . Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): I. Obstetrical complications and change in seizure frequency: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2009;50(5):1229–1236.
  • Rajiv KR, Radhakrishnan A. Status epilepticus in pregnancy: Etiology, management, and clinical outcomes. Epilepsy Behav. 2017;76:114–119.
  • Watila MM, Beida O, Kwari S, et al. Seizure occurrence, pregnancy outcome among women with active convulsive epilepsy: One year prospective study. Seizure. 2015;26:7–11.
  • Viinikainen K, Heinonen S, Eriksson K, et al. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia. 2006;47(1):186–192.
  • McMullan J, Sasson C, Pancioli A, et al. Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a Meta-analysis. Acad Emerg Med. 2010;17(6):575–582.
  • Cock H, ESETT Group. Established Status Epilepticus Treatment Trial (ESETT). Epilepsia. 2011;52(Suppl 8):50–2.
  • Sanacora G, Mason GF, Rothman DL, et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry. 2003;160(3):577–579.
  • Schindler K, Elger CE, Lehnertz K. Increasing synchronization may promote seizure termination: evidence from status epilepticus. Clin Neurophysiol. 2007;118(9):1955–1968.
  • Lerer B, Stanley M, Demetriou S, et al. Effect of electroconvulsive shock on muscarinic cholinergic receptors in rat cerebral cortex and hippocampus. J Neurochem. 1983;41(6):1680–1683.
  • Watkins CJ, Pei Q, Newberry NR. Differential effects of electroconvulsive shock on the glutamate receptor mRNAs for NR2A, NR2B and mGluR5b. Brain Res Mol Brain Res. 1998;61(1-2):108–113.
  • Pei Q, Burnet PW, Grahame-Smith DG, et al. Differential effects of acute and chronic electroconvulsive shock on the abundance of messenger RNAs for voltage-dependent potassium channel subunits in the rat brain. Neuroscience. 1997;78(2):343–350.
  • Gombos Z, Mendonça A, Racine RJ, et al. Long-term enhancement of entorhinal-dentate evoked potentials following “modified” ECS in the rat. Brain Res. 1997;766(1-2):168–172.
  • Mikkelsen JD, Woldbye D, Kragh J, et al. Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus. Brain Res Mol Brain Res. 1994;23(4):317–322.
  • Kragh J, Tønder N, Finsen BR, et al. Repeated electroconvulsive shocks cause transient changes in rat hippocampal somatostatin and neuropeptide Y immunoreactivity and mRNA in situ hybridization signals. Exp Brain Res. 1994;98(2):305–313.
  • Lindefors N, Brodin E, Metsis M. Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience. 1995;65(3):661–670.
  • Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995;15(11):7539–7547.
  • Wahlestedt C, Blendy JA, Kellar KJ, et al. Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat. Brain Res. 1990;507(1):65–68.
  • Smiałowska M, Bijak M, Sopala M, et al. Inhibitory effect of NPY on the picrotoxin-induced activity in the hippocampus: a behavioural and electrophysiological study. Neuropeptides. 1996;30(1):7–12.
  • Bijak M. Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes. Neurosci Lett. 1999;268(3):115–118.
  • André V, Ferrandon A, Marescaux C, et al. Electroshocks delay seizures and subsequent epileptogenesis but do not prevent neuronal damage in the lithium-pilocarpine model of epilepsy. Epilepsy Res. 2000;42(1):7–22.
  • Tørring N, Sanghani SN, Petrides G, et al. The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis. Acta Psychiatr Scand. 2017;135(5):388–397.
  • Andrade C. Dose calculation with brief-pulse ECT demystified. Indian J Psychiatry. 2010;52(3):276–278.
  • Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 1993;328(12):839–846.
  • Horne RL, Pettinati HM, Sugerman AA, et al. Comparing bilateral to unilateral electroconvulsive therapy in a randomized study with E.E.G monitoring. Arch Gen Psychiatry. 1985;42(11):1087–1092.
  • Weeks D, Freeman CPL, Kendell RE. ECT: III: Enduring cognitive deficits? Br J Psychiatry. 1980;137(1):26–37.
  • Abrams R, Taylor MA, Faber R, et al. Bilateral versus unilateral electroconvulsive therapy: Efficacy in melancholia. Am J Psychiatry. 1983;140(4):463–465.
  • Gregory S, Shawcross CR, Gill D. The nottingham ECT study. A double-blind comparison of bilateral, unilateral and simulated ECT in depressive illness. Br J Psychiatry. 1985;146(MAY):520–524.
  • Sackeim HA, Decina P, Kanzler M, et al. Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry. 1987;144(11):1449–1455.
  • Jaffe R. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging: a task force report of the American Psychiatric Association, 2nd ed. AJP. 2002;159(2):331–331.
  • Weiner RD, Coffey CE, Krystal AD. The monitoring and management of electrically induced seizures. Psychiatr Clin North Am. 1991;14(4):845–869.
  • Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: Impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am. 1991;14(4):803–843.
  • Shin HW, O’Donovan CA, Boggs JG, et al. Successful ECT treatment for medically refractory nonconvulsive status epilepticus in pediatric patient. Seizure. 2011;20(5):433–436.
  • Kalinowsky LB. Electric convulsive therapy, with emphasis on importance of adequate treatment. Arch Neurpsych. 1943;50(6):652.
  • Zeiler FA, Matuszczak M, Teitelbaum J, et al. Electroconvulsive therapy for refractory status epilepticus: a systematic review. Seizure. 2016;35:23–32.
  • Lisanby SH, Bazil CW, Resor SR, et al. ECT in the treatment of status epilepticus. J Ect. 2001;17(3):210–215.
  • Viparelli U, Viparelli G. ECT and grand mal epilepsy. Convuls Ther. 1992;8(1):39–42.
  • Carrasco González MD, Palomar M, Rovira R. Electroconvulsive therapy for status epilepticus. Ann Intern Med. 1997;127(3):247–248.
  • Regenold WT, Weintraub D, Taller A. Electroconvulsive therapy for epilepsy and major depression. Am J Geriatr Psychiatry. 1998;6(2):180–183.
  • Morales OG, Henry ME, Nobler MS, et al. Electroconvulsive therapy and repetitive transcranial magnetic stimulation in children and adolescents: a review and report of two cases of epilepsia partialis continua. Child Adolesc Psychiatr Clin N Am. 2005;14(1):193–210.
  • Lunde ME, Lee EK, Rasmussen KG. Electroconvulsive therapy in patients with epilepsy. Epilepsy Behav. 2006;9(2):355–359.
  • Cline JS, Roos K. Treatment of status epilepticus with electroconvulsive therapy. J Ect. 2007;23(1):30–32.
  • Koong F-J, Chen W-C. Maintaining electroconvulsive therapy for refractory epilepsy combined with psychotic symptoms. BMJ Case Rep. 2010;2010(dec21 1):bcr1120092506–bcr1120092506.
  • Kamel H, Cornes SB, Hegde M, et al. Electroconvulsive therapy for refractory status epilepticus: a case series. Neurocrit Care. 2010;12(2):204–210.
  • Pinchotti DM, Abbott C, Quinn DK. Targeted electroconvulsive therapy for super refractory status epilepticus: a case report and literature review. Psychosomatics. 2018;59(3):302–305.
  • Chan EL, Lee W, Koo C, et al. Electroconvulsive therapy for new-onset super-refractory status epilepticus. Hong Kong Med J. 2018;24(3):307–310.
  • Abstracts of the 5th joint meeting of the german, Austrian, and swiss sections of the international league against epilepsy basle, may 16?19, 2007. Epilepsia. 2007;48(s3):1–66.
  • Fernández-Torre JL, Kaplan PW, Rebollo M, et al. Ambulatory non-convulsive status epilepticus evolving into a malignant form. Epileptic Disord. 2012;14(1):41–50.
  • Griesemer DA, Kellner CH, Beale MD, et al. Electroconvulsive therapy for treatment of intractable seizures. Initial findings in two children. Neurology. 1997;49(5):1389–1392.
  • Incecik F, Horoz OO, Herguner OM, et al. Electroconvulsive therapy for refractory status epilepticus in a child: a case report. Ann Indian Acad Neurol. 2015;18:364–5.
  • Lambrecq V, Villéga F, Marchal C, et al. Refractory status epilepticus: Electroconvulsive therapy as a possible therapeutic strategy. Seizure. 2012;21(9):661–664.
  • Andrade C, Arumugham SS, Thirthalli J. Adverse effects of electroconvulsive therapy. Psychiatr Clin North Am. 2016;39(3):513–530.
  • Brigo F, Lattanzi S, Nardone R, et al. Intravenous brivaracetam in the treatment of status epilepticus: a systematic review. CNS Drugs. 2019;33(8):771–781.
  • Lattanzi S, Riva A, Striano P. Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy. Expert Rev Neurother. 2021;21(11):1317–1332.
  • Stephen LJ, Brodie MJ. Brivaracetam: a novel antiepileptic drug for focal-onset seizures. Ther Adv Neurol Disord. 2018;11:1756285617742081.
  • Yawno T, Miller SL, Bennet L, et al. Ganaxolone: a new treatment for neonatal seizures. Front Cell Neurosci. 2017;11:246.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.